Announcement no. 01/2020
6 January 2020
On 26 November 2019, Össur hf. initiated a share buy-back program, see Company
announcement no. 72/2019.
The purpose of the share buyback program is to reduce the Company's share
capital and adjust the capital structure by distributing capital to shareholders
in line with the Company's Capital Structure and Dividend Policy. The program
will end no later than 11 March 2020. The Company may purchase up to 5,000,000
shares under the program, corresponding to 1.2% of the current share capital.
The total consideration for shares purchased under the program shall not exceed
USD 10 million.
The following transactions have been made under the program in week 5, the
period 2 January - 3 January 2020:
Transactions
Date No. of Avg. purchase Transaction
shares price in DKK value in DKK
30 December 2019 - - -
31 December 2019 - - -
01 January 2020 - - -
02 January 2020 37,158 52.95 1,967,605
03 January 2020 3,766 54.22 204,188
Total 40,924 53.01 2,171,793
Össur has acquired 444,344 shares under the program at the average price of DKK
52.14. Following the above transactions Össur's holding of own shares is
3,400,555 corresponding to 0.80% of the Company's total share capital.
The share buyback program on Nasdaq Copenhagen is carried out in accordance with
Regulation No. 596/2014 of the European Parliament and of the Council on market
abuse ('MAR'), and the Commission delegated regulation No. 2016/1052.
Further information
David Hreidarsson, Investor Relations, dohreidarsson@ossur.com, +354 515 1380
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at
http://www.ossur.com/investors
About Össur
Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that
help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of Prosthetics and Bracing & Supports. A recognized
'Technology Pioneer,' Össur invests significantly in research and product
development-its award-winning designs ensuring a consistently strong position in
the market. Successful patient and clinical outcomes are further empowered via
Össur's educational programs and business solutions. Headquartered in Iceland,
Össur has major operations in the Americas, Europe and Asia, with additional
distributors worldwide. www.ossur.com
Attachments:
Share buy-back transactions 02.01.2020-03.01.2020.pdf
Share buy-back announcement_05 (05 01 2020).pdf
Attachments
- Original document
- Permalink
Disclaimer
NASDAQ OMX Nordic - NASDAQ OMX Stockholm AB published this content on 06 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 January 2020 16:02:01 UTC
